You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NantHealth's net loss more than tripled in the second quarter, though it continues to build up its cash reserves.
Genomic data analytics firm Sentieon uses the challenges to prove and increase customer confidence in its bioinformatics technology.
The company hopes to improve its Dragen analysis platform with data compression technology from Enancio and data management capabilities from BlueBee.
Nvidia customers in the US and the Middle East expect that the newly introduced A100 servers will accelerate research into the novel coronavirus.
Facing questions over data security in the US and Ireland, the company has changed its name as it looks to shed its China operations.
Because of coronavirus-related shutdowns of customer labs, the San Diego-based firm saw decreased revenues in all geographic regions, especially outside the US.
The INFORM study echoed the 2019 interim results from the NCI Pediatric MATCH trial, which found that 24 percent of participants were eligible for targeted treatment.
Fresh off a new investment round, the British firm seeks to help research labs and biopharma companies manage population-level genomics research.
Because of COVID-19, the San Diego-based firm said it was unable to ship new instruments and many users were unable to operate their existing ones.
The research suggests that pangolins are natural hosts of Betacoronaviruses but does not support the idea that SARS-CoV-2 emerged directly from pangolins.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.